Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
This study has been completed.
Sponsor:
Alcon Research
Information provided by:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00047593
First received: October 8, 2002
Last updated: August 4, 2008
Last verified: August 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.
| Condition | Intervention | Phase |
|---|---|---|
|
Open-Angle Glaucoma Ocular Hypertension |
Drug: IOP Lowering Medications |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | Phase 3 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Japanese Subjects C-01-98. |
Resource links provided by NLM:
Further study details as provided by Alcon Research:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Adults of Japanese Ethnicity
Contacts and Locations
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00047593 History of Changes |
| Other Study ID Numbers: | C-01-98, C-01-98 |
| Study First Received: | October 8, 2002 |
| Last Updated: | August 4, 2008 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by Alcon Research:
|
open-angle glaucoma ocular hypertension |
POAG Iris Pigmentation Japanese |
Additional relevant MeSH terms:
|
Glaucoma Glaucoma, Open-Angle Hypertension Ocular Hypertension |
Eye Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 16, 2013